SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $341,000 | +21.4% | 2,000 | 0.0% | 0.01% | +20.0% |
Q3 2020 | $281,000 | -12.5% | 2,000 | 0.0% | 0.01% | -28.6% |
Q2 2020 | $321,000 | +24.4% | 2,000 | 0.0% | 0.01% | +75.0% |
Q4 2019 | $258,000 | +14.2% | 2,000 | -33.3% | 0.00% | +33.3% |
Q3 2019 | $226,000 | -96.7% | 3,000 | -93.3% | 0.00% | -96.6% |
Q2 2019 | $6,814,000 | -34.8% | 44,845 | -48.8% | 0.09% | -36.7% |
Q1 2019 | $10,448,000 | +75.7% | 87,655 | +60.8% | 0.14% | +56.2% |
Q4 2018 | $5,948,000 | -43.2% | 54,505 | -15.9% | 0.09% | -32.6% |
Q3 2018 | $10,463,000 | +155.6% | 64,785 | +109.2% | 0.13% | +153.8% |
Q2 2018 | $4,094,000 | +83.8% | 30,975 | +3.0% | 0.05% | +85.7% |
Q1 2018 | $2,228,000 | +35.4% | 30,075 | +1.7% | 0.03% | +47.4% |
Q4 2017 | $1,646,000 | +1632.6% | 29,575 | +824.2% | 0.02% | +1800.0% |
Q2 2014 | $95,000 | -74.0% | 3,200 | -78.9% | 0.00% | -80.0% |
Q1 2014 | $365,000 | +15.5% | 15,200 | -1.9% | 0.01% | +25.0% |
Q4 2013 | $316,000 | -53.2% | 15,500 | +8.4% | 0.00% | -50.0% |
Q3 2013 | $675,000 | -6.4% | 14,300 | -24.5% | 0.01% | -20.0% |
Q2 2013 | $721,000 | – | 18,950 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |